Analyst: Dow Stock Has Double-Digit Return Potential

Upside is modest ahead of this weekend's Trump-Xi trade meeting

 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

MIDDAY MARKET CHECK     6/28/2019
Turn $1,000 into $1.57 Million - with "Holy Grail of Medicine" On September 10, 2018, a tiny biotech firm won a patent on a new treatment that can "Cut & Paste" any disease from your body. The Nobel Prize Committee called it "The Holy Grail of Medicine." This under-the-radar company is not yet a household name. Our research proves that anyone who gets in now could turn $1,000 into $1.57 Million >>>
JPMorgan, Goldman Keep Dow Higher at Midday By Karee Venema Share On The Dow Jones Industrial Average (DJI) is trading higher today, as big-cap bank stocks JPMorgan Chase (JPM) and Goldman Sachs (GS) pop after the Fed's annual stress tests opened the door for dividend hikes. However, the upside is modest as caution sets in ahead of this weekend's highly anticipated meeting between U.S. President Donald Trump and Chinese leader Xi Jinping. The S&P 500 Index (SPX) and Nasdaq Composite (IXIC) are gaining ground, too, and even as all three indexes are set to snap their weekly win streaks, they are boasting impressive June returns. Continue reading for more on today's market, including:  Analyst: This Dow stock has double-digit return potential. The bull note calling for AutoZone record highs. Plus, options bull targets emerging markets ETF; a big day for Constellation Brands; and the spice stock near the bottom of the S&P. >> Continue reading...
LATEST HEADLINES
>> This ETF Hasn't Ended July Lower in a Decade It's the only fund on our list with a 100% win rate >> The Energy Stock to Avoid Next Quarter XOM options are attractively priced >> Options Bulls Continue to Blitz Embattled Biogen Stock The biotech was downgraded at Piper Jaffray earlier >> Apple Stock Sinks on Ive Exit Apple is currently testing the $200 level >> Guggenheim Raises Outlook on Surging AutoZone Stock AutoZone stock recently hit an all-time high ADVERTISEMENT The #1 Biotech Stock to Own Today On September 10, 2018, a tiny biotech firm won a patent on a new treatment that can "Cut & Paste" any disease from your body. The Nobel Prize Committee called it "The Holy Grail of Medicine." This under-the-radar company is not yet a household name. Our research proves that anyone who gets in now could turn $1,000 into $1.57 Million >>>
To ensure delivery of Schaeffer's Midday Market Check, add us to your contacts! For more information, please visit this link for further instructions. This email was sent to phanhoa1821960.trader@blogger.com because you are a registered subscriber to Schaeffer's Midday Market Check or have signed up to receive emails from www.schaeffersresearch.com. Don't want to receive Schaeffer's Midday Market Check? You can unsubscribe here. For more information about our privacy practices, please review our Privacy Policy or our Terms & Conditions. Have a question, comment or concern? We’ll respond quickest if you call (800) 448-2080, email, or write to:
		SCHAEFFER'S MIDDAY MARKET CHECK enews@schaeffer.com 5151 Pfeiffer Rd. Suite 250 Cincinnati, OH, 45242 USA 800-448-2080 www.schaeffersresearch.com